TransMedics Group Inc. President and CEO Waleed H. Hassanein purchased approximately $2 million worth of company shares through the Waleed H. Hassanein Revocable Trust. The transactions took place over two days, including the acquisition of 8,400 shares at $118.68 per share on August 6, 2025. This insider buying activity has been noted alongside recent bullish market spreads for the stock. In contrast, Hims & Hers Health Inc. CEO Andrew Dudum sold 660,000 shares at $50.58 each, generating over $30 million from the sale. This represents the largest insider sale in the company's history. Notably, Dudum had encouraged investors on social media to increase their holdings in the company shortly before the sale was disclosed.